Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Bushen Yiqi Huoxue is a Traditional Chinese Medicine (TCM) herbal formula utilized in clinical research at Anhui Provincial Hospital for the treatment of diminished ovarian reserve (DOR). The formula's name reflects its core therapeutic principles in TCM: tonifying the kidney (Bushen), replenishing Qi (Yiqi), and promoting blood circulation (Huoxue). It is typically administered as an oral decoction. Clinical studies, including retrospective evaluations and molecular mechanism explorations, have investigated its ability to regulate mRNA expression and improve the ovarian microenvironment, potentially enhancing ovarian function and egg quality in women with ovarian reserve dysfunction.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on bushen yiqi huoxue traditional chinese medicine.